We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
Try the New Site
We're building a modernized ClinicalTrials.gov! Visit Beta.ClinicalTrials.gov to try the new functionality.
ClinicalTrials.gov Menu
Trial record 1 of 2 for:    SU.VI.MAX
Previous Study | Return to List | Next Study

Primary Prevention Trial of the Health Effects of Antioxidant Vitamins and Minerals.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00272428
Recruitment Status : Completed
First Posted : January 6, 2006
Last Update Posted : December 17, 2009
French private agencies
Information provided by:
Institut National de la Santé Et de la Recherche Médicale, France

Brief Summary:
It has been suggested that a low dietary intake of antioxidant vitamins and minerals increases the incidence rate of cardiovascular disease and cancer. To date, however, the published results of randomized, placebo-controlled trials of supplements containing antioxidant nutrients have not provided clear evidence of a beneficial effect. We tested the efficacy of nutritional doses of supplementation with a combination of antioxidant vitamins and minerals in reducing the incidence of cancer and ischemic cardiovascular disease in the general population.

Condition or disease Intervention/treatment Phase
Healthy Behavioral: ascorbic acid, vitamin E, beta carotene, selenium, zinc Phase 3

Detailed Description:

From experimental studies it is known that free radicals may induce numerous pathological processes, and it has been suggested that, because of their antioxidant capacity, nutrients such as beta-carotene, vitamin C, vitamin E, selenium and zinc may prevent such harmful effects. Epidemiological data from cross-sectional, case-control, and prospective studies have indeed shown a strong relationship between the intake of antioxidant vitamins and minerals, or foods rich in these nutrients, and the risk of cancer and ischaemic cardiovascular diseases (CVD). However, randomised placebo-controlled primary prevention trials, in which antioxidant micronutrients alone or in pairs were given at high doses over long periods, have not been able to prove this potential beneficial effect, and two of these even suggested harmful effects. The seemingly contradictory results between the observational studies and these randomised trials can be explained by the fact that the doses used in clinical trials were much higher than the highest levels reachable by usual dietary intake which have been found to be associated in observational studies with the lowest risk of cancer and CVD. In fact, the only trial which did observe a beneficial effect on total mortality and cancer incidence used nutritional doses of a combination of several vitamins and minerals and was performed on Chinese population with very low baseline micronutrient status, due to poor life conditions in this region (9).

The objective of the "SUpplementation en VItamines et Minéraux AntioXydants" (SU.VI.MAX) study, was to test in a randomised, placebo-controlled trial, if an adequate and well balanced intake of antioxidant nutrients reduces the incidence of cancers and ischaemic cardiovascular diseases in a middle-age general population.

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Enrollment : 13000 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Double
Primary Purpose: Prevention
Official Title: The SU.VI.MAX Study. A Randomized, Placebo-controlled Prevention Trial of the Health Effects of Antioxidant Vitamins and Minerals.
Study Start Date : October 1994
Actual Study Completion Date : September 2005

Resource links provided by the National Library of Medicine

Primary Outcome Measures :
  1. Major fatal and non fatal ischemic cardiovascular events
  2. Cancer any kind except for basal cell skin carcinoma

Secondary Outcome Measures :
  1. All cause mortality
  2. Health-related quality of life
  3. Intermediate criteria of clinical status
  4. Intermediate criteria of biological status
  5. Intermediate criteria of anthropometric status

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Layout table for eligibility information
Ages Eligible for Study:   35 Years to 60 Years   (Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes

Inclusion Criteria:

  • women aged 35-60 years, men aged 45-60 years
  • acceptance of the possibility to be given a placebo and acceptance of the constraints of participation
  • lack of previous regular supplementation with any of the vitamins or minerals in the supplement provided
  • absence of extreme beliefs or behavior regarding diet

Exclusion Criteria:

  • disease likely to hinder active participation or threatened 5-year survival

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00272428

Layout table for location information
U557 Inserm
Paris, France, 75003
Sponsors and Collaborators
Institut National de la Santé Et de la Recherche Médicale, France
French private agencies
Layout table for investigator information
Principal Investigator: Serge Hercberg, MD, PhD U557 Inserm (UMR Inserm/Inra/CNAM), Institut Scientifique et Technique de la Nutrition et de l'Alimentation/CNAM
Additional Information:
Publications of Results:
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):

Layout table for additonal information
ClinicalTrials.gov Identifier: NCT00272428    
Other Study ID Numbers: 94-706
First Posted: January 6, 2006    Key Record Dates
Last Update Posted: December 17, 2009
Last Verified: October 2007
Keywords provided by Institut National de la Santé Et de la Recherche Médicale, France:
Prevention trial
Antioxydant vitamins and minerals
Ischemic disease
Health related quality of life
Additional relevant MeSH terms:
Layout table for MeSH terms
Ascorbic Acid
Vitamin E
Beta Carotene
Physiological Effects of Drugs
Molecular Mechanisms of Pharmacological Action
Protective Agents
Trace Elements